Soma vs. Baclofen

See how Soma and Baclofen compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Soma is a short-term, Schedule IV controlled substance for acute musculoskeletal pain, while baclofen is a non-controlled antispasmodic approved for longer-term spasticity from MS or spinal cord injury.

  • Baclofen causes drowsiness and weakness more often in trials, but Soma carries a higher risk of abuse, misuse, and dependence.

  • Baclofen is titrated upward over about nine to ten days, while Soma is started at a fixed dose taken three times daily plus bedtime from day one.

Soma vs. Baclofen Drug Summary

Soma

Soma (carisoprodol) is a skeletal muscle relaxant approved in 1959 for short-term relief of acute, painful musculoskeletal conditions in adults. It is taken as an oral tablet, usually three times a day and at bedtime, for no more than two to three weeks.

Baclofen

Baclofen is a GABA-B receptor agonist approved in 1977 to treat spasticity from multiple sclerosis or spinal cord injury. It comes in tablets, liquid, granules, or an intrathecal pump, and is titrated up over about ten days to a maintenance dose.

Soma vs. Baclofen Side Effects

Soma

Most common
drowsiness (up to 17%)
dizziness (>2%)
headache (>2%)
tachycardia (postmarketing)

Baclofen

Most common
drowsiness (up to 63%)
dizziness (up to 15%)
weakness (up to 15%)
nausea (4 to 12%)

Soma vs. Baclofen Dosage

Soma

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 250 mg to 350 mg TID + HS Day 1 onward
Maximum dose 250 mg to 350 mg TID + HS Same as starting
Dose changes None Fixed dose

Baclofen

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 5 mg three times daily Days 1-3
Maximum dose 20 mg three times daily Day 10 onward
Dose changes 3 increases Every 3 days

Soma vs. Baclofen Indications

Soma

Soma is FDA-approved only for short-term relief of acute, painful musculoskeletal conditions in adults, typically for no more than two to three weeks. It is not approved for chronic pain, long-term use, or use in children.

  • Short-term relief of acute musculoskeletal pain

  • Used alongside rest and physical therapy

  • Not approved for chronic pain conditions

  • Not approved for pediatric use

Baclofen

Baclofen is FDA-approved for spasticity caused by multiple sclerosis or spinal cord injury or disease, and severe spasticity can be treated with an intrathecal pump. It is not approved for spasticity from stroke, cerebral palsy, or Parkinson's disease.

  • Spasticity from multiple sclerosis

  • Spasticity from spinal cord injury or disease

  • Severe spasticity via intrathecal pump

  • Off-label: alcohol cravings, hiccups, GERD

Soma vs. Baclofen Pros and Cons

Soma

Soma works quickly for acute muscle spasm but is a Schedule IV controlled substance with real potential for misuse and dependence. It is intended for short courses only, not ongoing management of chronic conditions.

Pros

  • Fast-acting for acute muscle spasm

  • Simple fixed dosing schedule (TID + HS)

  • Long history of clinical use since 1959

Cons

  • Schedule IV controlled substance with abuse risk

  • Limited to 2 to 3 weeks of use

  • Sedation can impair driving or machine use

  • Additive CNS depression with alcohol, opioids, benzodiazepines

Baclofen

Baclofen is not a controlled substance and is approved for longer-term management of spasticity from neurological conditions. It requires a gradual titration up to the maintenance dose and carries serious risks if stopped abruptly.

Pros

  • Not a controlled substance

  • Approved for longer-term spasticity management

  • Available in tablet, liquid, granule, and pump forms

Cons

  • Higher rates of drowsiness and weakness in trials

  • Requires gradual titration over about 9 to 10 days

  • Abrupt stopping can cause seizures or rebound spasticity

  • Dose must be lowered in kidney impairment

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.